サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/05/02 | 3,950 | 3,955 | 3,900 | 3,925 | -5 | -0.1% | 71,500 |
2023/05/01 | 3,905 | 3,940 | 3,885 | 3,930 | +5 | +0.1% | 133,000 |
2023/04/28 | 3,885 | 3,940 | 3,885 | 3,925 | +75 | +1.9% | 177,100 |
2023/04/27 | 3,840 | 3,855 | 3,810 | 3,850 | +15 | +0.4% | 98,500 |
2023/04/26 | 3,900 | 3,905 | 3,830 | 3,835 | -60 | -1.5% | 141,900 |
2023/04/25 | 3,880 | 3,905 | 3,860 | 3,895 | +20 | +0.5% | 99,400 |
2023/04/24 | 3,865 | 3,890 | 3,860 | 3,875 | +20 | +0.5% | 71,200 |
2023/04/21 | 3,820 | 3,865 | 3,805 | 3,855 | +25 | +0.7% | 84,200 |
2023/04/20 | 3,850 | 3,850 | 3,820 | 3,830 | -15 | -0.4% | 65,100 |
2023/04/19 | 3,830 | 3,855 | 3,820 | 3,845 | ±0 | ±0% | 91,500 |
2023/04/18 | 3,860 | 3,865 | 3,835 | 3,845 | -5 | -0.1% | 83,900 |
2023/04/17 | 3,865 | 3,880 | 3,840 | 3,850 | -15 | -0.4% | 84,700 |
2023/04/14 | 3,855 | 3,875 | 3,845 | 3,865 | +35 | +0.9% | 139,800 |
2023/04/13 | 3,810 | 3,830 | 3,795 | 3,830 | +20 | +0.5% | 76,300 |
2023/04/12 | 3,825 | 3,830 | 3,775 | 3,810 | +15 | +0.4% | 98,200 |
2023/04/11 | 3,780 | 3,810 | 3,770 | 3,795 | +45 | +1.2% | 128,800 |
2023/04/10 | 3,735 | 3,755 | 3,730 | 3,750 | +40 | +1.1% | 95,700 |
2023/04/07 | 3,700 | 3,735 | 3,700 | 3,710 | +10 | +0.3% | 102,500 |
2023/04/06 | 3,685 | 3,715 | 3,670 | 3,700 | +10 | +0.3% | 111,600 |
2023/04/05 | 3,740 | 3,740 | 3,680 | 3,690 | -45 | -1.2% | 107,300 |
2023/04/04 | 3,695 | 3,735 | 3,670 | 3,735 | +50 | +1.4% | 104,000 |
2023/04/03 | 3,685 | 3,685 | 3,655 | 3,685 | +35 | +1% | 68,600 |
2023/03/31 | 3,640 | 3,675 | 3,630 | 3,650 | +15 | +0.4% | 105,500 |
2023/03/30 | 3,685 | 3,690 | 3,620 | 3,635 | -80 | -2.2% | 95,700 |
2023/03/29 | 3,700 | 3,715 | 3,675 | 3,715 | +40 | +1.1% | 131,400 |
2023/03/28 | 3,685 | 3,690 | 3,665 | 3,675 | +15 | +0.4% | 55,100 |
2023/03/27 | 3,660 | 3,680 | 3,640 | 3,660 | +20 | +0.5% | 119,900 |
2023/03/24 | 3,590 | 3,640 | 3,590 | 3,640 | +30 | +0.8% | 87,400 |
2023/03/23 | 3,575 | 3,625 | 3,555 | 3,610 | +10 | +0.3% | 142,700 |
2023/03/22 | 3,615 | 3,625 | 3,570 | 3,600 | +35 | +1% | 128,900 |
2023/03/20 | 3,630 | 3,635 | 3,565 | 3,565 | -85 | -2.3% | 160,400 |
2023/03/17 | 3,650 | 3,655 | 3,625 | 3,650 | +35 | +1% | 164,300 |
2023/03/16 | 3,615 | 3,645 | 3,600 | 3,615 | -45 | -1.2% | 135,600 |
2023/03/15 | 3,655 | 3,675 | 3,630 | 3,660 | +15 | +0.4% | 169,400 |
2023/03/14 | 3,700 | 3,700 | 3,620 | 3,645 | -100 | -2.7% | 231,800 |
2023/03/13 | 3,720 | 3,760 | 3,705 | 3,745 | -20 | -0.5% | 235,600 |
2023/03/10 | 3,760 | 3,790 | 3,750 | 3,765 | +10 | +0.3% | 214,200 |
2023/03/09 | 3,730 | 3,775 | 3,725 | 3,755 | +20 | +0.5% | 121,300 |
2023/03/08 | 3,710 | 3,750 | 3,695 | 3,735 | -20 | -0.5% | 189,500 |
2023/03/07 | 3,730 | 3,765 | 3,730 | 3,755 | +15 | +0.4% | 121,100 |
2023/03/06 | 3,730 | 3,760 | 3,720 | 3,740 | +5 | +0.1% | 99,800 |
2023/03/03 | 3,730 | 3,740 | 3,715 | 3,735 | +15 | +0.4% | 92,400 |
2023/03/02 | 3,685 | 3,720 | 3,685 | 3,720 | +45 | +1.2% | 95,300 |
2023/03/01 | 3,750 | 3,755 | 3,675 | 3,675 | -95 | -2.5% | 189,700 |
2023/02/28 | 3,770 | 3,795 | 3,770 | 3,770 | -5 | -0.1% | 113,600 |
2023/02/27 | 3,775 | 3,805 | 3,765 | 3,775 | -50 | -1.3% | 141,300 |
2023/02/24 | 3,815 | 3,845 | 3,805 | 3,825 | +15 | +0.4% | 164,100 |
2023/02/22 | 3,790 | 3,815 | 3,775 | 3,810 | +5 | +0.1% | 197,400 |
2023/02/21 | 3,770 | 3,805 | 3,755 | 3,805 | +15 | +0.4% | 132,700 |
2023/02/20 | 3,810 | 3,820 | 3,765 | 3,790 | +5 | +0.1% | 124,200 |
501~
550
件表示中 / 1011件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 176,100円 | +5.9% | +24.5% | 3.12% | 11.68倍 | 1.10倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
サンバイオ | 331,000円 | - | - | 0.00% | - | 153.31倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 171,800円 | +5.0% | +1.5% | 0.00% | 14.70倍 | 3.91倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 389,000円 | +3.6% | +6.1% | 3.08% | 13.10倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム